Vaxart, Inc. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
Vaxart, Inc. (VXRT) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $4.50 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2021-11-04
- Vaxart, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2021-09-30 was $3.30M.
- Vaxart, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2020-09-30 was $0.00.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month |
|---|---|---|---|
| 2021-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.50M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.20M 10-Q · filed 2021-08-05 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |